Medical Aesthetic Devices Market is expected to grow at a CAGR of 11.46% by 2030, estimates DelveInsight

The global medical aesthetic devices market was valued at USD 13,533.26 million in 2023 and is projected to grow at a CAGR of 11.46% from 2024 to 2030, reaching USD 25,808.43 million by 2030. Market growth is largely driven by the rapid increase in the aging population and the rising adoption of aesthetic procedures. Growing awareness about physical appearance and the availability of diverse cosmetic treatments worldwide are also fueling demand. Furthermore, the shift toward less invasive and non-invasive procedures, the rising prevalence of obesity, and continuous technological advancements in aesthetic devices are expected to significantly contribute to the market's expansion during the forecast period (2024-2030).

DelveInsight's Medical Aesthetic Devices Market Insights report provides the current and forecast market analysis, individual leading Medical Aesthetic Devices companies' market shares, challenges, Medical Aesthetic Devices market drivers, barriers, and trends, and key Medical Aesthetic Devices companies in the market.

Request for a sample page report @ https://www.delveinsight.com/report-store/medical-aesthetic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Key Takeaways from the Medical Aesthetic Devices Market Report
The Medical Aesthetic Devices market is projected to grow at a moderate CAGR from 2024 to 2030.
As per DelveInsight estimates, North America is anticipated to dominate the global Medical Aesthetic Devices market during the forecast period.
Notable Medical Aesthetic Devices companies such as Johnson & Johnson, HansBioMed., AbbVie Inc., Sebbin, Sientra, Inc., POLYTECH Health & Aesthetics GmbH, Suneva Medical, Hanson Medical Inc., SurgiSil, Surgiform Technologies LLC, Alma Lasers, Candela Medical., Lumenis., Cutera., Sciton Inc, Merz Pharma GmbH & Co.KGaA, Bausch Health Companies Inc., Venus Concept., TRIA BEAUTY, Cynosure Inc., GALDERMA, and several others are currently operating in the Medical Aesthetic Devices market.
In May 2021, GC Aesthetics, Inc., a privately held medical technology company specializing in aesthetic solutions, introduced its next-generation breast implants, PERLETM.
In February 2021, Galderma received approval from the U.S. Food and Drug Administration (FDA) for Restylane Defyne, indicated for the augmentation and correction of mild to moderate chin retrusion in adults aged 21 and older.
In November 2020, Lutronic launched IntelliSTIM, a third-generation body sculpting device featuring advanced intelligent muscle stimulation technology.

To read more about the latest highlights related to the Medical Aesthetic Devices market, get a snapshot of the key highlights entailed in the Global Medical Aesthetic Devices Market Report https://www.delveinsight.com/sample-request/medical-aesthetic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Medical Aesthetic Devices Overview

Medical aesthetic devices are specialized equipment and technologies designed to enhance cosmetic appearance through surgical, minimally invasive, or non-invasive procedures. These devices are widely used for improving body contouring, skin tightening, facial aesthetics, and hair removal, as well as for correcting or reducing the effects of aging, obesity, and other conditions affecting physical appearance.

Medical Aesthetic Devices Market Insights

North America is projected to account for a significant share of the global medical aesthetic devices market in 2023 and is expected to maintain this leading position throughout the forecast period. This dominance can be attributed to the rising number of cosmetic surgeries, the growing prevalence of obesity, trauma-related cases, and breast cancer, as well as the strong presence of major market players and advanced healthcare infrastructure in the region.

According to the American Society of Plastic Surgeons (2020), around 15.6 million cosmetic procedures were carried out in the U.S., including 2.3 million surgical and 13.2 million minimally invasive procedures. Similarly, the International Society of Aesthetic Plastic Surgery (2020) reported that Mexico recorded about 404,229 non-surgical cosmetic procedures in the same year, with botulinum toxin treatments accounting for 48.0% of all minimally invasive procedures.

These factors collectively highlight the robust demand for medical aesthetic devices in North America, reinforcing its market leadership.

To know more about why North America is leading the market growth in the Medical Aesthetic Devices market, get a snapshot of the Medical Aesthetic Devices Market Outlook https://www.delveinsight.com/report-store/medical-aesthetic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Medical Aesthetic Devices Market Dynamics

The medical aesthetic devices market is expected to grow significantly, driven by the rising number of cosmetic procedures performed worldwide.

According to the International Society of Aesthetic Plastic Surgery (2021), global cosmetic surgeries increased from 10,129,528 in 2020 to 12,840,688 in 2021. The same source reported that in 2021, there were 477,705 facelift procedures, 290,844 neck lifts, 290,107 brow lifts, 113,206 thigh lifts, 140,158 upper arm lifts, 96,312 lower body lifts, and 63,190 buttock lifts performed globally. Additionally, popular procedures included 1,903,063 liposuctions, 1,685,471 breast augmentations, 1,446,890 eyelid surgeries, 995,149 rhinoplasties, and 991,361 abdominoplasties.

In comparison, 2020 saw approximately 3,913,679 face and neck procedures, 3,062,897 breast surgeries, and 3,152,952 body and extremities procedures performed worldwide. This consistent growth in cosmetic surgeries highlights the rising demand for medical aesthetic devices, which is projected to fuel market expansion between 2023 and 2030.

Furthermore, the increasing global geriatric population is expected to further drive market demand. Age-related changes such as sagging facial skin around the eyes, cheeks, and jowls, along with rough or dry skin, are leading more older individuals to seek aesthetic treatments. Surveys also suggest a growing acceptance of cosmetic surgery among people over 50, adding to the market's growth potential.

Medical Aesthetic Devices Market Drivers:
Increase in the number of aesthetically conscious population across the globe
Growing preference for minimally invasive and non-invasive aesthetic procedures

Get a sneak peek at the Medical Aesthetic Devices market dynamics @ https://www.delveinsight.com/sample-request/medical-aesthetic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Scope of the Medical Aesthetic Devices Market Report:
Coverage: Global
Study Period: 2022 to 2030
Key Medical Aesthetic Devices Companies: Johnson & Johnson, HansBioMed., AbbVie Inc., Sebbin, Sientra, Inc., POLYTECH Health & Aesthetics GmbH, Suneva Medical, Hanson Medical Inc., SurgiSil, Surgiform Technologies LLC, Alma Lasers, Candela Medical., Lumenis., Cutera., Sciton Inc, Merz Pharma GmbH & Co.KGaA, Bausch Health Companies Inc., Venus Concept., TRIA BEAUTY, Cynosure Inc., GALDERMA, and others.

Which MedTech key players in the Medical Aesthetic Devices market are set to emerge as the trendsetter, explore @ Medical Aesthetic Devices Companies https://www.delveinsight.com/report-store/medical-aesthetic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Trending Reports By DelveInsight:

Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market

Leber's Hereditary Optic Neuropathy Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market

Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market

Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market

Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market

Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market

Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market

Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market

Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market

Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market

Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market

Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market

Hypoplastic Left Heart Syndrome Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market

Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market

Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market

Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market

Clinically Isolated Syndrome Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market

Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market

Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market

Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market

Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market

Contact Info:

Kritika Rehani
Assistant Manager, Digital Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
www.delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.